Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for American Healthcare REIT (AHR) over the last 10 years, with Q3 2025 value amounting to $185.7 million.

  • American Healthcare REIT's Cash from Financing Activities rose 145580.46% to $185.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.1 million, marking a year-over-year increase of 862275.54%. This contributed to the annual value of -$134.7 million for FY2024, which is 440.18% down from last year.
  • American Healthcare REIT's Cash from Financing Activities amounted to $185.7 million in Q3 2025, which was up 145580.46% from $33.1 million recorded in Q2 2025.
  • American Healthcare REIT's Cash from Financing Activities' 5-year high stood at $185.7 million during Q3 2025, with a 5-year trough of -$140.0 million in Q4 2024.
  • For the 5-year period, American Healthcare REIT's Cash from Financing Activities averaged around -$925315.8, with its median value being -$12.0 million (2022).
  • Per our database at Business Quant, American Healthcare REIT's Cash from Financing Activities plummeted by 227862.36% in 2024 and then surged by 145580.46% in 2025.
  • Over the past 5 years, American Healthcare REIT's Cash from Financing Activities (Quarter) stood at -$44.2 million in 2021, then fell by 15.24% to -$50.9 million in 2022, then surged by 88.44% to -$5.9 million in 2023, then plummeted by 2278.62% to -$140.0 million in 2024, then surged by 232.65% to $185.7 million in 2025.
  • Its last three reported values are $185.7 million in Q3 2025, $33.1 million for Q2 2025, and -$23.8 million during Q1 2025.